Ingrid A. Lie
Oslo, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Normative Modelling of Brain Volume in Multiple Sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2025
Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 19, 2022
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 26, 2022
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 03, 2021
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Journal: European radiology
Published: June 11, 2021
A man in his twenties with dizziness, double vision and peripheral facial palsy.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: October 03, 2018
Treatment non-adherence as a trigger for status epilepticus: An observational, retrospective study based on therapeutic drug monitoring.
Journal: Epilepsy research
Published: February 07, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026